Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lower SHBG levels may increase the risk of PCOS.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

A systematic approach is crucial for managing hair loss in women.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Stem cell therapies show the most promise for anti-aging benefits.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

The apelinergic system might protect the heart from damage caused by doxorubicin.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Sheep wool follicles absorb different amino acids at various rates and locations, which could affect wool growth based on diet and genetics.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Certain genes are linked to skin aging, like wrinkles and pigmentation changes.